文献速递类风湿关节炎

类风湿关节炎临床缓解患者亚临床滑膜炎症的组织学与转录证据

Histologic and Transcriptional Evidence of Subclinical Synovial Inflammation in Patients With Rheumatoid Arthritis in Clinical Remission.
PubMed 文献 · Arthritis Rheumatol · 2019-06-05

该研究对135例接受关节置换的类风湿关节炎患者比较DAS28与滑膜组织学,并对35例进行RNA-Seq分析。结果显示临床缓解和低疾病活动度患者中分别有27%和31%存在滑膜炎症组织学证据,亚临床滑膜炎与CRP和抗CCP抗体升高相关,且其滑膜基因表达特征与临床活动性疾病相似。

要点

  • 临床缓解的RA患者中27%仍有滑膜炎症组织学证据。
  • 低疾病活动度患者中31%存在亚临床滑膜炎,与CRP和抗CCP升高相关。
  • 亚临床滑膜炎的滑膜基因表达特征与临床活动性疾病高度重叠。

核心结论

  • 低临床疾病活动度的RA患者中31%存在亚临床滑膜炎的组织学证据,且与CRP和抗CCP抗体水平升高相关。
  • 亚临床滑膜炎患者滑膜基因表达特征与临床活动性疾病相似,提示临床缓解可能未完全消除滑膜炎症。

研究设计与样本

  • 研究比较135例接受关节置换的RA患者的DAS28与滑膜组织学特征,并对其中35例 subset 进行RNA-Seq数据与DAS28的比较。

主要发现

  • 滑膜组织学分析显示,缓解患者中27%、低疾病活动度患者中31%的样本存在滑膜炎。
  • 低疾病活动度且伴滑膜炎的患者相比无滑膜炎者CRP升高(P=0.0006),抗CCP抗体水平升高(P=0.03)。
  • 与「低炎症滑膜」亚型相比,亚临床滑膜炎患者滑膜中183个基因差异表达,其中86%也在临床活动性疾病(DAS28≥3.2)滑膜中差异表达。

关键数值与推荐

  • 临床缓解定义为DAS28<2.6,低疾病活动度定义为DAS28<3.2。
  • 亚临床滑膜炎与CRP升高(P=0.0006)及抗CCP抗体升高(P=0.03)相关。
  • 亚临床滑膜炎滑膜中183个基因差异表达,86%与临床活动性疾病重叠。

临床怎么用

  • 对达到临床缓解或低疾病活动度的RA患者,应警惕亚临床滑膜炎的存在,尤其当CRP或抗CCP抗体升高时。
  • DAS28缓解可能不足以反映滑膜炎症控制情况,滑膜组织学或转录特征有助于识别持续炎症患者。

局限性

  • 研究样本来自接受关节置换的患者,可能存在选择偏倚。
  • RNA-Seq分析仅限35例子集,样本量有限。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Patients with rheumatoid arthritis (RA) in clinical remission may have subclinical synovial inflammation. This study was undertaken to determine the proportion of patients with RA in remission or with low disease activity at the time of arthroplasty who had histologic or transcriptional evidence of synovitis, and to identify clinical features that distinguished patients as having subclinical synovitis. METHODS: We compared Disease Activity Score in 28 joints (DAS28) to synovial histologic features in 135 patients with RA undergoing arthroplasty. We also compared DAS28 scores to RNA-Seq data in a subset of 35 patients. RESULTS: Fourteen percent of patients met DAS28 criteria for clinical remission (DAS28 <2.6), and another 15% met criteria for low disease activity (DAS28 <3.2). Histologic analysis of synovium revealed synovitis in 27% and 31% of samples from patients in remission and patients with low disease activity, respectively. Patients with low disease activity and synovitis also exhibited increased C-reactive protein (CRP) (P = 0.0006) and increased anti-cyclic citrullinated peptide (anti-CCP) antibody levels (P = 0.03) compared to patients without synovitis. Compared to patients with a "low inflammatory synovium" subtype, 183 genes were differentially expressed in the synovium of patients with subclinical synovitis. The majority of these genes (86%) were also differentially expressed in the synovium of patients with clinically active disease (DAS28 ≥3.2). CONCLUSION: Thirty-one percent of patients with low clinical disease activity exhibited histologic evidence of subclinical synovitis, which was associated with increased CRP and anti-CCP levels. Our findings suggest that synovial gene expression signatures of clinical synovitis are present in patients with subclinical synovitis.

来源:Arthritis Rheumatol,查看原文。版权归原作者所有。

引用

  1. Orange DE, Agius P, DiCarlo EF, et al. Histologic and Transcriptional Evidence of Subclinical Synovial Inflammation in Patients With Rheumatoid Arthritis in Clinical Remission. Arthritis Rheumatol. 2019. PMID: 30835943. doi:10.1002/art.40878

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。